Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis

Cannabinoid 1 Receptor Blockade Reduces Atherosclerosis with Enhances Reverse Cholesterol Transport

(2011) Koichi Sugamura et al.   Journal of Atherosclerosis and Thrombosis

Cannabinoid 1 receptor-dependent transactivation of fibroblast growth factor receptor 1 emanates from lipid rafts and amplifies extracellular signal-regulated kinase 1/2 activation in embryonic cortical neurons

(2011) Olga Asimaki et al.   JOURNAL OF NEUROCHEMISTRY

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy

(2010) F. Barutta et al.   DIABETES

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

(2010) T. Jourdan et al.   DIABETES

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents

(2009) Simona Pisanti et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells

(2009) Aymen I. Idris et al.   Cell Metabolism

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

(2009) Antonietta Santoro et al.   INTERNATIONAL JOURNAL OF CANCER

Endocannabinoid system modulation in cancer biology and therapy

(2009) Simona Pisanti et al.   PHARMACOLOGICAL RESEARCH

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

(2008) István Katona et al.   NATURE MEDICINE

Loss of Cannabinoid Receptor CB1 Induces Preterm Birth

(2008) Haibin Wang et al.   PLoS One